Research Nester published a report titled “Anatomic Pathology Market: Global Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the global anatomic pathology market in terms of market segmentation by type, subdivision, application, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global anatomic pathology market is anticipated to grow with a CAGR of ~9% during the forecast period, i.e., 2023-2033. The market is segmented by type intoservices, consumables, and instruments. Amongst these segments, the servicessegment – 48.12%held the largest sharein 2022, backed by the growing number of breast cancers along with the surge in the number of biopsies done worldwide. For instance, over 17 720 biopsies were recommended and performed, in between January 2019 to September 2020 in the United States.

The global anatomic pathology market is estimated to garner a revenue of ~USD 59424 million by the end of 2033, backed by the increasing number of kidney diseases worldwide. Various features provided by anatomic pathology, including identification of abnormalities which help in diagnoses of disease and manage treatmentare also projected to boost recommendation of pathological tests in the coming years.Moreover, bowel diseases as well as increasing number of lab tests performedis also projected to propel the growth of the market during the forecast period.

Browse Full Research Report@ https://www.researchnester.com/reports/veterinary-imaging-market/4326

Geographically, the global anatomic pathology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America held the largest market share of 39.21%in 2022,backed by the presence of a strong healthcare network in the region, growing number of hospitals and diagnostic centers, as well as the rising demand for advanced anatomic pathology amongst the healthcare service providers owing to the rising number of surgeries in the region.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Increasing Number of Cancer Cases & Biopsies to Drive the Market Growth

According to the data, around17 720 biopsies were recommended and performed, in between January 2019 to September 2020 in United States.

The increasing number of biopsies is expected to accelerate the market growth in the coming years, as biopsies help health care providers to determine whether the cells are cancerous. Moreover, the increasing number of tests as well as the increasing growth cancer cases are also expected to drive the growth of the global anatomic pathology market during the forecast period.

However, high expenditure associated in developing anatomic pathology as well as non-availability of refurbished anatomic pathology equipmentare expected to operate as key restraints to the growth of global anatomic pathology market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the of global anatomic pathology market which includes company profiling ofPHC Holdings Corporation, Indica Labs, Inc., Laboratory Corporation of America Holdings, F.Hoffmann-La Roche AG, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics Laboratories, Inc., Agilent Technologies, Inc.The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the of global anatomic pathology marketthat will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Sample Request Report@ https://www.researchnester.com/sample-request-4326

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919